Life Sciences Tools and Services
Company Overview of Syros Pharmaceuticals, Inc.
Syros Pharmaceuticals, Inc., a life sciences company, focuses on treating disease by mapping gene regulatory circuits and modulating the factors that regulate gene expression. The company was founded in 2011 and is based in Watertown, Massachusetts.
480 Arsenal Street
Watertown, MA 02472
Founded in 2011
Key Executives for Syros Pharmaceuticals, Inc.
Chief Executive Officer and Director
Scientific Founder and Member of Scientific Advisory Board
Chief Financial Officer and Chief Product Officer
Compensation as of Fiscal Year 2014.
Syros Pharmaceuticals, Inc. Key Developments
Syros Pharmaceuticals Appoints Jorge Conde as Chief Financial Officer and Chief Product Officer
Jun 10 14
Syros Pharmaceuticals announced that Jorge Conde has joined Syros' executive leadership team as its Chief Financial Officer (CFO) and Chief Product Officer. Mr. Conde will lead the platform strategy for Syros' novel gene regulation technology and manage the overall finances for the company. Prior to joining Syros, Mr. Conde co-founded Knome with George Church, Professor of Genetics at Harvard Medical School, based on genomic technologies developed in Professor Church's laboratory. Mr. Conde was most recently CFO at Knome.
Syros Pharmaceuticals, Inc. Presents at The 21st Annual Future Leaders in the Biotech Industry Conference, Mar-28-2014 01:40 PM
Feb 11 14
Syros Pharmaceuticals, Inc. Presents at The 21st Annual Future Leaders in the Biotech Industry Conference, Mar-28-2014 01:40 PM. Venue: Millennium Broadway Hotel & Conference Center, New York, New York, United States.
Syros Pharmaceuticals Appoints Stéphane Bancel to the Board of Directors
Nov 21 13
Syros Pharmaceuticals announced that Stéphane Bancel, President and Founding Chief Executive Officer (CEO) of Moderna Therapeutics, and Senior Partner at Flagship Ventures, has joined its Board of Directors.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries